The picture has changed. I see progress for Quest's Lung Dx and the pre-IND solid tumour study.
Not shown is that multitude of other key collaborations. These collaborations are particularly valuable IMHO because the offer significant upside potential on the back of 3rd party investment. CDY shareholders contribute ... but not to an extent that will break the bank.
cheers
pipeline update
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
